Lee Frego
Boehringer Ingelheim (United States)(US)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, Mass Spectrometry Techniques and Applications, CAR-T cell therapy research
Most-Cited Works
- → Selective targeting of the IL23 pathway: Generation and characterization of a novel high-affinity humanized anti-IL23A antibody(2015)122 cited
- → Discovery and Characterization of a Substrate Selective p38α Inhibitor(2004)110 cited
- → Generation and functional characterization of anti-human and anti-mouse IL-36R antagonist monoclonal antibodies(2017)85 cited
- → A Steric Antagonism of Actin Polymerization by a Salmonella Virulence Protein(2006)85 cited
- → Design and characterization of Zweimab and Doppelmab, high affinity dual antagonistic anti-TSLP/IL13 bispecific antibodies(2018)52 cited
- → Catalysis and Function of the p38α·MK2a Signaling Complex(2004)51 cited
- → Conformational changes of the glucocorticoid receptor ligand binding domain induced by ligand and cofactor binding, and the location of cofactor binding sites determined by hydrogen/deuterium exchange mass spectrometry(2006)50 cited
- → Crystal structure and receptor-interacting residues of MYDGF — a protein mediating ischemic tissue repair(2019)30 cited
- → Micro‐high‐performance liquid chromatography/Fourier transform mass spectrometry with electron‐capture dissociation for the analysis of protein enzymatic digests(2002)28 cited
- → Characterization of the Binding Site for Inhibitors of the HPV11 E1−E2 Protein Interaction on the E2 Transactivation Domain by Photoaffinity Labeling and Mass Spectrometry(2004)21 cited